United States · FDA National Drug Code directory
Chlordiazepoxide Hydrochloride and Clidinium Bromide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-731_541259c3-7b51-4c46-a11c-f199d185ace0
- Product NDC
- 67877-731
- Form
- CAPSULE
- Composition / generic term
- Chlordiazepoxide Hydrochloride and Clidinium Bromide
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210427
- Source listing expiry
- 20261231
Source-listed ingredients
- CHLORDIAZEPOXIDE HYDROCHLORIDE — 5 mg/1
- CLIDINIUM BROMIDE — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (67877-731-01) · 67877-731-01
- 500 CAPSULE in 1 BOTTLE (67877-731-05) · 67877-731-05
- 100 BLISTER PACK in 1 CARTON (67877-731-38) / 10 CAPSULE in 1 BLISTER PACK (67877-731-33) · 67877-731-38
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →